Cargando…
New horizons in non-small-cell lung cancer patients with ipsilateral pleural dissemination (M1a): review of the literature
Non-small cell lung cancer (NSCLC) with ipsilateral pleural dissemination (pM1a) is generally contraindicated for surgery owing to the extremely poor survival. However, some studies have demonstrated that primary tumor resection (PTR) may prolong the survival of these patients. Besides, with the dev...
Autores principales: | Li, Hao, Liu, Taorui, Sun, Zewen, Wang, Zhenfan, Liu, Xianping, Yang, Fan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8263880/ https://www.ncbi.nlm.nih.gov/pubmed/34350274 http://dx.doi.org/10.21037/atm-20-6188 |
Ejemplares similares
-
Hyperthermic intrathoracic chemotherapy (HITHOC) should be included in the guidelines for malignant pleural mesothelioma
por: Migliore, Marcello, et al.
Publicado: (2021) -
Present and future of hyperthermic intrathoracic chemotherapy (HITHOC) in thoracic surgical oncology
por: Migliore, Marcello
Publicado: (2021) -
Hyperthermic intrathoracic chemotherapy (HITHOC): narrative review of the current literature, recommendations and future studies
por: Markowiak, Till, et al.
Publicado: (2021) -
A narrative review of hyperthermic intrathoracic chemotherapy for advanced lung cancer
por: Song, Kimberly, et al.
Publicado: (2021) -
Perioperative anaesthetic management of patients undergoing thoracic cytoreductive surgery and HITHOC
por: Unigarro-Londoño, Felipe, et al.
Publicado: (2021)